141 related articles for article (PubMed ID: 8221671)
1. Sequence-specific interaction of a conformational domain of p53 with DNA.
Srinivasan R; Roth JA; Maxwell SA
Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
[TBL] [Abstract][Full Text] [Related]
2. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
Srinivasan R; Maxwell SA
Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
[TBL] [Abstract][Full Text] [Related]
3. Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
Maxwell SA; Roth JA
Oncogene; 1993 Dec; 8(12):3421-6. PubMed ID: 8247546
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
5. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
Stürzbecher HW; Brain R; Addison C; Rudge K; Remm M; Grimaldi M; Keenan E; Jenkins JR
Oncogene; 1992 Aug; 7(8):1513-23. PubMed ID: 1321401
[TBL] [Abstract][Full Text] [Related]
6. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism.
Hainaut P; Rolley N; Davies M; Milner J
Oncogene; 1995 Jan; 10(1):27-32. PubMed ID: 7824276
[TBL] [Abstract][Full Text] [Related]
7. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
Schmieg FI; Simmons DT
Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
[TBL] [Abstract][Full Text] [Related]
8. p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence.
Niewolik D; Vojtesek B; Kovarik J
Oncogene; 1995 Mar; 10(5):881-90. PubMed ID: 7898929
[TBL] [Abstract][Full Text] [Related]
9. Complex of simian virus large T antigen and p53 can bind DNA specifically.
Long SB; Ho HY; Chen CL; Lai MD
Anticancer Res; 1995; 15(4):1375-80. PubMed ID: 7654024
[TBL] [Abstract][Full Text] [Related]
10. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
Iwabuchi K; Li B; Bartel P; Fields S
Oncogene; 1993 Jun; 8(6):1693-6. PubMed ID: 8502489
[TBL] [Abstract][Full Text] [Related]
11. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
Martin DW; Subler MA; Muñoz RM; Brown DR; Deb SP; Deb S
Biochem Biophys Res Commun; 1993 Aug; 195(1):428-34. PubMed ID: 8395834
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of MAR/SAR DNA-elements by mutant p53.
Müller BF; Paulsen D; Deppert W
Oncogene; 1996 May; 12(9):1941-52. PubMed ID: 8649855
[TBL] [Abstract][Full Text] [Related]
13. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
Wolkowicz R; Elkind NB; Ronen D; Rotter V
Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
[TBL] [Abstract][Full Text] [Related]
14. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
15. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
Hainaut P; Milner J
Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
[TBL] [Abstract][Full Text] [Related]
16. 9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein.
Sugikawa E; Tsunoda S; Nakanishi N; Ohashi M
Anticancer Res; 2001; 21(4A):2671-5. PubMed ID: 11724337
[TBL] [Abstract][Full Text] [Related]
17. Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.
Tarunina M; Jenkins JR
Oncogene; 1993 Nov; 8(11):3165-73. PubMed ID: 8414520
[TBL] [Abstract][Full Text] [Related]
18. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
[TBL] [Abstract][Full Text] [Related]
19. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
McLure KG; Lee PW
EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
[TBL] [Abstract][Full Text] [Related]
20. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
